(lp0
S'Sunesis Pharmaceuticals  CFO Resigns StreetInsider.com - Apr 12, 2017 On April 7, 2017, Eric H. Bjerkholt, Executive Vice President, Corporate Development and Finance, Chief Financial Officer and Corporate Secretary of Sunesis Pharmaceuticals, Inc. , informed the Company of his resignation from all of his&nbsp;...Favorable News Coverage Extremely Likely to Effect Sunesis Pharmaceuticals ... - The Cerbat Gem'
p1
aS'Sunesis Pharmaceuticals Announces Presentation of The Ohio State University ... GlobeNewswire  - Apr 3, 2017 SOUTH SAN FRANCISCO, Calif., April 03, 2017  -- Sunesis Pharmaceuticals, Inc.  today announced results from an Ohio State University-sponsored preclinical study evaluating the efficacy of non-covalent BTK inhibitor&nbsp;...'
p2
aS'Sunesis Pharmaceuticals Announces 1-for-6 Reverse Stock Split GlobeNewswire  - Sep 7, 2016 SOUTH SAN FRANCISCO, Calif., Sept. 07, 2016  -- Sunesis Pharmaceuticals, Inc.  today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-6&nbsp;...'
p3
aS'Sunesis Pharmaceuticals Inc. SNSS  Wall Street Journal - Feb 12, 2011 News Sunesis Pharmaceuticals Inc.SNSS. Significant News Only. 04/03/17; Press Release. Sunesis Pharmaceuticals Announces Presentation of The Ohio State University-Sponsored Preclinical Study of BTK Inhibitor SNS-062 at AACR Annual Meeting.'
p4
aS"Sunesis Pharmaceuticals Announces Poster Presentation on Preliminary Results ... GlobeNewswire  - Sep 1, 2016 SOUTH SAN FRANCISCO, Calif., Sept. 01, 2016  -- Sunesis Pharmaceuticals, Inc.  today announced that a poster detailing preliminary results from the Company's Phase 1A study in healthy volunteers evaluating oral&nbsp;..."
p5
aS'Sunesis Pharmaceuticals  Receiving Somewhat Critical Media Coverage ... Markets Daily - 11 hours ago Sunesis Pharmaceuticals logo Media coverage about Sunesis Pharmaceuticals  has trended somewhat negative recently, Alpha One Sentiment reports.Street Consensus Update on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS ... - Davidson RegisterKUEHNE&amp;NAGEL INTL UNSP ADR EACH REPR 0.20 ORD  Analysts See $0.30 EPS ... - NormanObserver.com'
p6
aS'SUNESIS PHARMACEUTICALS, INC.  Files An 8-K Results of Operations ... Market Exclusive - Mar 9, 2017 Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers.Attention Seeker Stocks: Sunesis Pharmaceuticals, Inc. , Pioneer ... - KC Register'
p7
aS'Sunesis to Host Conference Call on March 9th to Discuss Fourth Quarter and ... GlobeNewswire  - Mar 2, 2017 SOUTH SAN FRANCISCO, Calif., March 02, 2017  -- Sunesis Pharmaceuticals, Inc.  today announced that it will host a conference call on Thursday, March 9, 2017 at 11:00 a.m.'
p8
aS"Sunesis Pharmaceuticals Announces Presentation of Positive Results from MD ... GlobeNewswire  - Jun 13, 2016 Sunesis also announced that follow-up data from the company's VALOR trial was presented as an e-poster during the EHA meeting."
p9
aS'Does Sunesis Pharmaceuticals, Inc.  Have Sufficient Cash To ... Scibility Media - Aug 1, 2016 Sunesis Pharmaceuticals, Inc.  continues to lose money as its latest financial results for 2Q2016 and 1H2016 show.'
p10
a.